APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug Containment Solution

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Drug Containment Solution Market Analysis and Forecast 2026-2032

5 July 2026179 pages

Choose your research edition.

Industry ResearchDrug Containment Solution Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug Containment Solution Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Drug Containment Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug Containment Solution Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug Containment Solution Market Analysis and Forecast 2026-2032179 pages · $4,950 USD

Market perspective

The global Drug Containment Solution market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Drug Containment Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Drug Containment Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Drug Containment Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Drug Containment Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Drug Containment Solution include Stevanato Group, BD, AptarGroup, Hergesheimer AG, Catalent, Inc., West Pharmaceutical Services, Inc., Schott AG, Stearate Group and NIPRO, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Drug Containment Solution, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Drug Containment Solution, also provides the revenue of main regions and countries. Of the upcoming market potential for Drug Containment Solution, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drug Containment Solution revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Drug Containment Solution market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Drug Containment Solution revenue, projected growth trends, production technology, application and end-user industry.

Drug Containment Solution Segment by Company

Stevanato Group

BD

AptarGroup

Hergesheimer AG

Catalent, Inc.

West Pharmaceutical Services, Inc.

Schott AG

Stearate Group

NIPRO

Owen Mumford Limited

Psalmed AG

Drug Containment Solution Segment by Type

Vials

Ampoules

Bottles

Drug Containment Solution Segment by Application

Hospitals

Clinics

Home Care Settings

Ambulatory Surgical Centers

Drug Containment Solution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Containment Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug Containment Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Containment Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Drug Containment Solution in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Drug Containment Solution company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Containment Solution revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drug Containment Solution Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Vials Major Player Table 3. Ampoules Major Player Table 4. Bottles Major Player Table 5. Global Drug Containment Solution Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospitals Major Player Table 7. Clinics Major Player Table 8. Home Care Settings Major Player Table 9. Ambulatory Surgical Centers Major Player Table 10. Drug Containment Solution Industry Trends Table 11. Drug Containment Solution Industry Drivers Table 12. Drug Containment Solution Industry Opportunities and Challenges Table 13. Drug Containment Solution Industry Restraints Table 14. Global Drug Containment Solution Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Drug Containment Solution Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Drug Containment Solution Market Share by Region (2021-2026) Table 17. Global Drug Containment Solution Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Drug Containment Solution Market Share by Region (2027-2032) Table 19. Global Drug Containment Solution Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Drug Containment Solution Revenue Market Share by Players (2021-2026) Table 21. Global Drug Containment Solution Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Drug Containment Solution Key Players Headquarters & Area Served Table 23. Global Drug Containment Solution Players, Product Type & Application Table 24. Global Drug Containment Solution Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Drug Containment Solution by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Drug Containment Solution Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Drug Containment Solution Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Drug Containment Solution Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Drug Containment Solution Revenue Market Share by Type (2021-2026) Table 31. Global Drug Containment Solution Revenue Market Share by Type (2027-2032) Table 32. Global Drug Containment Solution Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Drug Containment Solution Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Drug Containment Solution Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Drug Containment Solution Revenue Market Share by Application (2021-2026) Table 36. Global Drug Containment Solution Revenue Market Share by Application (2027-2032) Table 37. Stevanato Group Company Information Table 38. Stevanato Group Business Overview Table 39. Stevanato Group Drug Containment Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Stevanato Group Drug Containment Solution Product Portfolio Table 41. Stevanato Group Recent Development Table 42. BD Company Information Table 43. BD Business Overview Table 44. BD Drug Containment Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. BD Drug Containment Solution Product Portfolio Table 46. BD Recent Development Table 47. AptarGroup Company Information Table 48. AptarGroup Business Overview Table 49. AptarGroup Drug Containment Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. AptarGroup Drug Containment Solution Product Portfolio Table 51. AptarGroup Recent Development Table 52. Hergesheimer AG Company Information Table 53. Hergesheimer AG Business Overview Table 54. Hergesheimer AG Drug Containment Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Hergesheimer AG Drug Containment Solution Product Portfolio Table 56. Hergesheimer AG Recent Development Table 57. Catalent, Inc. Company Information Table 58. Catalent, Inc. Business Overview Table 59. Catalent, Inc. Drug Containment Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Catalent, Inc. Drug Containment Solution Product Portfolio Table 61. Catalent, Inc. Recent Development Table 62. West Pharmaceutical Services, Inc. Company Information Table 63. West Pharmaceutical Services, Inc. Business Overview Table 64. West Pharmaceutical Services, Inc. Drug Containment Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. West Pharmaceutical Services, Inc. Drug Containment Solution Product Portfolio Table 66. West Pharmaceutical Services, Inc. Recent Development Table 67. Schott AG Company Information Table 68. Schott AG Business Overview Table 69. Schott AG Drug Containment Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Schott AG Drug Containment Solution Product Portfolio Table 71. Schott AG Recent Development Table 72. Stearate Group Company Information Table 73. Stearate Group Business Overview Table 74. Stearate Group Drug Containment Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Stearate Group Drug Containment Solution Product Portfolio Table 76. Stearate Group Recent Development Table 77. NIPRO Company Information Table 78. NIPRO Business Overview Table 79. NIPRO Drug Containment Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. NIPRO Drug Containment Solution Product Portfolio Table 81. NIPRO Recent Development Table 82. Owen Mumford Limited Company Information Table 83. Owen Mumford Limited Business Overview Table 84. Owen Mumford Limited Drug Containment Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Owen Mumford Limited Drug Containment Solution Product Portfolio Table 86. Owen Mumford Limited Recent Development Table 87. Psalmed AG Company Information Table 88. Psalmed AG Business Overview Table 89. Psalmed AG Drug Containment Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Psalmed AG Drug Containment Solution Product Portfolio Table 91. Psalmed AG Recent Development Table 92. North America Drug Containment Solution Revenue by Type (2021-2026) & (US$ Million) Table 93. North America Drug Containment Solution Revenue by Type (2027-2032) & (US$ Million) Table 94. North America Drug Containment Solution Revenue by Application (2021-2026) & (US$ Million) Table 95. North America Drug Containment Solution Revenue by Application (2027-2032) & (US$ Million) Table 96. North America Drug Containment Solution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. North America Drug Containment Solution Revenue by Country (2021-2026) & (US$ Million) Table 98. North America Drug Containment Solution Revenue by Country (US$ Million) & (2027-2032) Table 99. Europe Drug Containment Solution Revenue by Type (2021-2026) & (US$ Million) Table 100. Europe Drug Containment Solution Revenue by Type (2027-2032) & (US$ Million) Table 101. Europe Drug Containment Solution Revenue by Application (2021-2026) & (US$ Million) Table 102. Europe Drug Containment Solution Revenue by Application (2027-2032) & (US$ Million) Table 103. Europe Drug Containment Solution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Europe Drug Containment Solution Revenue by Country (2021-2026) & (US$ Million) Table 105. Europe Drug Containment Solution Revenue by Country (US$ Million) & (2027-2032) Table 106. China Drug Containment Solution Revenue by Type (2021-2026) & (US$ Million) Table 107. China Drug Containment Solution Revenue by Type (2027-2032) & (US$ Million) Table 108. China Drug Containment Solution Revenue by Application (2021-2026) & (US$ Million) Table 109. China Drug Containment Solution Revenue by Application (2027-2032) & (US$ Million) Table 110. Asia Drug Containment Solution Revenue by Type (2021-2026) & (US$ Million) Table 111. Asia Drug Containment Solution Revenue by Type (2027-2032) & (US$ Million) Table 112. Asia Drug Containment Solution Revenue by Application (2021-2026) & (US$ Million) Table 113. Asia Drug Containment Solution Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia Drug Containment Solution Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 115. Asia Drug Containment Solution Revenue by Region (US$ Million) & (2021-2026) Table 116. Asia Drug Containment Solution Revenue by Region (US$ Million) & (2027-2032) Table 117. SAMEA Drug Containment Solution Revenue by Type (2021-2026) & (US$ Million) Table 118. SAMEA Drug Containment Solution Revenue by Type (2027-2032) & (US$ Million) Table 119. SAMEA Drug Containment Solution Revenue by Application (2021-2026) & (US$ Million) Table 120. SAMEA Drug Containment Solution Revenue by Application (2027-2032) & (US$ Million) Table 121. SAMEA Drug Containment Solution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. SAMEA Drug Containment Solution Revenue by Country (2021-2026) & (US$ Million) Table 123. SAMEA Drug Containment Solution Revenue by Country (US$ Million) & (2027-2032) Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Drug Containment Solution Image Figure 2. Global Drug Containment Solution Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug Containment Solution Market Size Share 2021 VS 2025 VS 2032 Figure 4. Vials Image Figure 5. Ampoules Image Figure 6. Bottles Image Figure 7. Global Drug Containment Solution Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Drug Containment Solution Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospitals Image Figure 10. Clinics Image Figure 11. Home Care Settings Image Figure 12. Ambulatory Surgical Centers Image Figure 13. Global Drug Containment Solution Market Size (US$ Million) & (2021-2032) Figure 14. Global Drug Containment Solution Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Drug Containment Solution Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Drug Containment Solution Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Drug Containment Solution Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Drug Containment Solution Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Drug Containment Solution Revenue Market Share by Type (2021-2032) Figure 21. Global Drug Containment Solution Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Drug Containment Solution Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Drug Containment Solution Revenue Market Share by Application (2021-2032) Figure 24. North America Drug Containment Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Drug Containment Solution Revenue Share by Type (2021-2032) Figure 26. North America Drug Containment Solution Revenue Share by Application (2021-2032) Figure 27. North America Drug Containment Solution Revenue Share by Country (2021-2032) Figure 28. United States Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Drug Containment Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Drug Containment Solution Revenue Share by Type (2021-2032) Figure 33. Europe Drug Containment Solution Revenue Share by Application (2021-2032) Figure 34. Europe Drug Containment Solution Revenue Share by Country (2021-2032) Figure 35. Germany Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Drug Containment Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Drug Containment Solution Revenue Share by Type (2021-2032) Figure 45. China Drug Containment Solution Revenue Share by Application (2021-2032) Figure 46. Asia Drug Containment Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Drug Containment Solution Revenue Share by Type (2021-2032) Figure 48. Asia Drug Containment Solution Revenue Share by Application (2021-2032) Figure 49. Asia Drug Containment Solution Revenue Share by Region (2021-2032) Figure 50. Japan Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Drug Containment Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Drug Containment Solution Revenue Share by Type (2021-2032) Figure 58. SAMEA Drug Containment Solution Revenue Share by Application (2021-2032) Figure 59. SAMEA Drug Containment Solution Revenue Share by Country (2021-2032) Figure 60. Brazil Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Drug Containment Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Vials
  • Ampoules
  • Bottles
Applications
  • Hospitals
  • Clinics
  • Home Care Settings
  • Ambulatory Surgical Centers
Companies covered
  • Stevanato Group
  • BD
  • AptarGroup
  • Hergesheimer AG
  • Catalent, Inc.
  • West Pharmaceutical Services, Inc.
  • Schott AG
  • Stearate Group
  • NIPRO
  • Owen Mumford Limited
  • Psalmed AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Drug Containment Solution Market by Type
  3. 1.2.1 Global Drug Containment Solution Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Vials
  5. 1.2.3 Ampoules
  6. 1.2.4 Bottles
  7. 1.3 Drug Containment Solution Market by Application
  8. 1.3.1 Global Drug Containment Solution Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospitals
  10. 1.3.3 Clinics
  11. 1.3.4 Home Care Settings
  12. 1.3.5 Ambulatory Surgical Centers
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Drug Containment Solution Market Dynamics
  1. 2.1 Drug Containment Solution Industry Trends
  2. 2.2 Drug Containment Solution Industry Drivers
  3. 2.3 Drug Containment Solution Industry Opportunities and Challenges
  4. 2.4 Drug Containment Solution Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Drug Containment Solution Market Perspective (2021-2032)
  2. 3.2 Global Drug Containment Solution Growth Trends by Region
  3. 3.2.1 Global Drug Containment Solution Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Drug Containment Solution Market Size by Region (2021-2026)
  5. 3.2.3 Global Drug Containment Solution Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Drug Containment Solution Revenue by Players
  2. 4.1.1 Global Drug Containment Solution Revenue by Players (2021-2026)
  3. 4.1.2 Global Drug Containment Solution Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Drug Containment Solution Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Drug Containment Solution Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Drug Containment Solution Key Players Headquarters & Area Served
  7. 4.4 Global Drug Containment Solution Players, Product Type & Application
  8. 4.5 Global Drug Containment Solution Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Drug Containment Solution Market CR5 and HHI
  11. 4.6.3 2025 Drug Containment Solution Tier 1, Tier 2, and Tier 3
5 Drug Containment Solution Market Size by Type
  1. 5.1 Global Drug Containment Solution Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Drug Containment Solution Revenue by Type (2021-2032)
  3. 5.3 Global Drug Containment Solution Revenue Market Share by Type (2021-2032)
6 Drug Containment Solution Market Size by Application
  1. 6.1 Global Drug Containment Solution Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Drug Containment Solution Revenue by Application (2021-2032)
  3. 6.3 Global Drug Containment Solution Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Stevanato Group
  2. 7.1.1 Stevanato Group Company Information
  3. 7.1.2 Stevanato Group Business Overview
  4. 7.1.3 Stevanato Group Drug Containment Solution Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Stevanato Group Drug Containment Solution Product Portfolio
  6. 7.1.5 Stevanato Group Recent Developments
  7. 7.2 BD
  8. 7.2.1 BD Company Information
  9. 7.2.2 BD Business Overview
  10. 7.2.3 BD Drug Containment Solution Revenue and Gross Margin (2021-2026)
  11. 7.2.4 BD Drug Containment Solution Product Portfolio
  12. 7.2.5 BD Recent Developments
  13. 7.3 AptarGroup
  14. 7.3.1 AptarGroup Company Information
  15. 7.3.2 AptarGroup Business Overview
  16. 7.3.3 AptarGroup Drug Containment Solution Revenue and Gross Margin (2021-2026)
  17. 7.3.4 AptarGroup Drug Containment Solution Product Portfolio
  18. 7.3.5 AptarGroup Recent Developments
  19. 7.4 Hergesheimer AG
  20. 7.4.1 Hergesheimer AG Company Information
  21. 7.4.2 Hergesheimer AG Business Overview
  22. 7.4.3 Hergesheimer AG Drug Containment Solution Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Hergesheimer AG Drug Containment Solution Product Portfolio
  24. 7.4.5 Hergesheimer AG Recent Developments
  25. 7.5 Catalent, Inc.
  26. 7.5.1 Catalent, Inc. Company Information
  27. 7.5.2 Catalent, Inc. Business Overview
  28. 7.5.3 Catalent, Inc. Drug Containment Solution Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Catalent, Inc. Drug Containment Solution Product Portfolio
  30. 7.5.5 Catalent, Inc. Recent Developments
  31. 7.6 West Pharmaceutical Services, Inc.
  32. 7.6.1 West Pharmaceutical Services, Inc. Company Information
  33. 7.6.2 West Pharmaceutical Services, Inc. Business Overview
  34. 7.6.3 West Pharmaceutical Services, Inc. Drug Containment Solution Revenue and Gross Margin (2021-2026)
  35. 7.6.4 West Pharmaceutical Services, Inc. Drug Containment Solution Product Portfolio
  36. 7.6.5 West Pharmaceutical Services, Inc. Recent Developments
  37. 7.7 Schott AG
  38. 7.7.1 Schott AG Company Information
  39. 7.7.2 Schott AG Business Overview
  40. 7.7.3 Schott AG Drug Containment Solution Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Schott AG Drug Containment Solution Product Portfolio
  42. 7.7.5 Schott AG Recent Developments
  43. 7.8 Stearate Group
  44. 7.8.1 Stearate Group Company Information
  45. 7.8.2 Stearate Group Business Overview
  46. 7.8.3 Stearate Group Drug Containment Solution Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Stearate Group Drug Containment Solution Product Portfolio
  48. 7.8.5 Stearate Group Recent Developments
  49. 7.9 NIPRO
  50. 7.9.1 NIPRO Company Information
  51. 7.9.2 NIPRO Business Overview
  52. 7.9.3 NIPRO Drug Containment Solution Revenue and Gross Margin (2021-2026)
  53. 7.9.4 NIPRO Drug Containment Solution Product Portfolio
  54. 7.9.5 NIPRO Recent Developments
  55. 7.10 Owen Mumford Limited
  56. 7.10.1 Owen Mumford Limited Company Information
  57. 7.10.2 Owen Mumford Limited Business Overview
  58. 7.10.3 Owen Mumford Limited Drug Containment Solution Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Owen Mumford Limited Drug Containment Solution Product Portfolio
  60. 7.10.5 Owen Mumford Limited Recent Developments
  61. 7.11 Psalmed AG
  62. 7.11.1 Psalmed AG Company Information
  63. 7.11.2 Psalmed AG Business Overview
  64. 7.11.3 Psalmed AG Drug Containment Solution Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Psalmed AG Drug Containment Solution Product Portfolio
  66. 7.11.5 Psalmed AG Recent Developments
8 North America
  1. 8.1 North America Drug Containment Solution Revenue (2021-2032)
  2. 8.2 North America Drug Containment Solution Revenue by Type (2021-2032)
  3. 8.2.1 North America Drug Containment Solution Revenue by Type (2021-2026)
  4. 8.2.2 North America Drug Containment Solution Revenue by Type (2027-2032)
  5. 8.3 North America Drug Containment Solution Revenue Share by Type (2021-2032)
  6. 8.4 North America Drug Containment Solution Revenue by Application (2021-2032)
  7. 8.4.1 North America Drug Containment Solution Revenue by Application (2021-2026)
  8. 8.4.2 North America Drug Containment Solution Revenue by Application (2027-2032)
  9. 8.5 North America Drug Containment Solution Revenue Share by Application (2021-2032)
  10. 8.6 North America Drug Containment Solution Revenue by Country
  11. 8.6.1 North America Drug Containment Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Drug Containment Solution Revenue by Country (2021-2026)
  13. 8.6.3 North America Drug Containment Solution Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Drug Containment Solution Revenue (2021-2032)
  2. 9.2 Europe Drug Containment Solution Revenue by Type (2021-2032)
  3. 9.2.1 Europe Drug Containment Solution Revenue by Type (2021-2026)
  4. 9.2.2 Europe Drug Containment Solution Revenue by Type (2027-2032)
  5. 9.3 Europe Drug Containment Solution Revenue Share by Type (2021-2032)
  6. 9.4 Europe Drug Containment Solution Revenue by Application (2021-2032)
  7. 9.4.1 Europe Drug Containment Solution Revenue by Application (2021-2026)
  8. 9.4.2 Europe Drug Containment Solution Revenue by Application (2027-2032)
  9. 9.5 Europe Drug Containment Solution Revenue Share by Application (2021-2032)
  10. 9.6 Europe Drug Containment Solution Revenue by Country
  11. 9.6.1 Europe Drug Containment Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Drug Containment Solution Revenue by Country (2021-2026)
  13. 9.6.3 Europe Drug Containment Solution Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Drug Containment Solution Revenue (2021-2032)
  2. 10.2 China Drug Containment Solution Revenue by Type (2021-2032)
  3. 10.2.1 China Drug Containment Solution Revenue by Type (2021-2026)
  4. 10.2.2 China Drug Containment Solution Revenue by Type (2027-2032)
  5. 10.3 China Drug Containment Solution Revenue Share by Type (2021-2032)
  6. 10.4 China Drug Containment Solution Revenue by Application (2021-2032)
  7. 10.4.1 China Drug Containment Solution Revenue by Application (2021-2026)
  8. 10.4.2 China Drug Containment Solution Revenue by Application (2027-2032)
  9. 10.5 China Drug Containment Solution Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Drug Containment Solution Revenue (2021-2032)
  2. 11.2 Asia Drug Containment Solution Revenue by Type (2021-2032)
  3. 11.2.1 Asia Drug Containment Solution Revenue by Type (2021-2026)
  4. 11.2.2 Asia Drug Containment Solution Revenue by Type (2027-2032)
  5. 11.3 Asia Drug Containment Solution Revenue Share by Type (2021-2032)
  6. 11.4 Asia Drug Containment Solution Revenue by Application (2021-2032)
  7. 11.4.1 Asia Drug Containment Solution Revenue by Application (2021-2026)
  8. 11.4.2 Asia Drug Containment Solution Revenue by Application (2027-2032)
  9. 11.5 Asia Drug Containment Solution Revenue Share by Application (2021-2032)
  10. 11.6 Asia Drug Containment Solution Revenue by Country
  11. 11.6.1 Asia Drug Containment Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Drug Containment Solution Revenue by Country (2021-2026)
  13. 11.6.3 Asia Drug Containment Solution Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Drug Containment Solution Revenue (2021-2032)
  2. 12.2 SAMEA Drug Containment Solution Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Drug Containment Solution Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Drug Containment Solution Revenue by Type (2027-2032)
  5. 12.3 SAMEA Drug Containment Solution Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Drug Containment Solution Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Drug Containment Solution Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Drug Containment Solution Revenue by Application (2027-2032)
  9. 12.5 SAMEA Drug Containment Solution Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Drug Containment Solution Revenue by Country
  11. 12.6.1 SAMEA Drug Containment Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Drug Containment Solution Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Drug Containment Solution Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst